Lack of Association of Cadherin Expression and Histopathologic Type, Metastasis, or Patient Outcome in Oropharyngeal Squamous Cell Carcinoma: A Tissue Microarray Study

Head and Neck Pathology

Volumn 6, Issue 1, 2012, Pages 38-47

  Ukpo, O C ^a   Thorstad, W L ^a   Zhang, Q ^a   Lewis Jr , J S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

E cadherin; Human papillomavirus; Immunohistochemistry; N cadherin; Oropharyngeal; p16; Squamous cell carcinoma; Survival

Indexed keywords

CADHERIN; CDH2 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

AGED; ARTICLE; DNA MICROARRAY; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; OROPHARYNX TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA; SURVIVAL; TUMOR RECURRENCE;

AGED; ANTIGENS, CD; CADHERINS; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OROPHARYNGEAL NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84858792574     PISSN: 1936055X     EISSN: 19360568     Source Type: Journal    
DOI: 10.1007/s12105-011-0306-7     Document Type: Article

References (31)

1. Ukpo OC, Pritchett CV, Lewis JE, et al. Human papillomavirus-associated oropharyngeal squamous cell carcinomas: primary tumor burden and survival in surgical patients. Ann Otol Rhinol Laryngol. 2009; 118(5): 368-73.
2. Ritchie JM, Smith EM, Summersgill KF, et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer. 2003; 104(3): 336-44.
3. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010; 363(16): 1576.
4. El-Mofty SK, Patil S. Human papillomavirus (HPV)-related oropharyngeal nonkeratinizing squamous cell carcinoma: characterization of a distinct phenotype. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 101(3): 339-45.
5. El-Mofty SK, Lu DW. Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol. 2003; 27(11): 1463-70.
6. Chernock RD, El-Mofty SK, Thorstad WL, et al. HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome. Head Neck Pathol. 2009; 3(3): 186-94.
7. Adelstein DJ, Ridge JA, Gillison ML, et al. Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D. C. Head Neck 2009; 31(11): 1393-422.
8. Mattijssen V, Peters HM, Schalkwijk L, et al. E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome. Int J Cancer. 1993; 55(4): 580-5.
9. Duband JL, Dufour S, Hatta K, et al. Adhesion molecules during somitogenesis in the avian embryo. J Cell Biol. 1987; 104(5): 1361-74.
10. Karayiannakis AJ, Syrigos KN, Chatzigianni E, et al. E-cadherin expression as a differentiation marker in gastric cancer. Hepatogastroenterology. 1998; 45(24): 2437-42.
11. Syrigos KN, Krausz T, Waxman J, et al. E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: correlation with histopathological grade, tumour stage and survival. Int J Cancer. 1995; 64(6): 367-70.
12. Karayiannakis AJ, Syrigos KN, Chatzigianni E, et al. Aberrant E-cadherin expression associated with loss of differentiation and advanced stage in human pancreatic cancer. Anticancer Res. 1998; 18(6A): 4177-80.
13. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol. 1998; 153(2): 333-9.
14. Shnayder Y, Kuriakose MA, Yee H, et al. Adhesion molecules as prognostic factors in nasopharyngeal carcinoma. Laryngoscope. 2001; 111(10): 1842-6.
15. Margulis A, Zhang W, Alt-Holland A, et al. E-cadherin suppression accelerates squamous cell carcinoma progressioin in three-dimensional, human tissue constructs. Cancer Res. 65: 1783-1791.
16. Margulis A, Zhang W, Alt-Holland A, et al. Loss of intercellular adhesion activates a transition from low- to high-grade human squamous cell carcinoma. Int J Cancer. 2006; 118: 821-31.
17. Franchi A, Gallo O, Boddi V, et al. Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination. Clin Cancer Res. 1996; 2(10): 1801-8.
18. Schipper JH, Frixen UH, Behrens J, et al. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res. 1991; 51(23 Pt 1): 6328-37.
19. Kawano T, Nakamura Y, Yanoma S, et al. Expression of E-cadherin, and CD44 s and CD44v6 and its association with prognosis in head and neck cancer. Auris Nasus Larynx. 2004; 31(1): 35-41.
20. Mannarini L, Kratochvil V, Calabrese L, et al. Human papilloma virus (HPV) in head and neck region: review of literature. Acta Otorhinolaryngol Ital. 2009; 29(3): 119-26.
21. Li S, Jiao J, Lu Z, Zhang M. An essential role for N-cadherin and beta-catenin for progression in tongue squamous cell carcinoma and their effect on invasion and metastasis of Tca8113 tongue cancer cells. Oncol Rep. 2009; 21(5): 1223-33.
22. Pyo SW, Hashimoto M, Kim YS, et al. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome. J Craniomaxillofac Surg. 2007; 35(1): 1-9.
23. Bosch FX, Andl C, Abel U, et al. E-cadherin is a selective and strongly dominant prognostic factor in squamous cell carcinoma: a comparison of E-cadherin with desmosomal components. Int J Cancer. 2005; 114(5): 779-90.
24. Foschini MP, Cocchi R, Morandi L, et al. E-cadherin loss and Delta Np73L expression in oral squamous cell carcinomas showing aggressive behavior. Head Neck. 2008; 30(11): 1475-82.
25. Al Moustafa AE, Foulkes WD, Benlimame N, et al. E6/E7 proteins of HPV type 16 and ErbB-2 cooperate to induce neoplastic transformation of primary normal oral epithelial cells. Oncogene. 2004; 23(2): 350-8.
26. Stenner M, Yosef B, Huebbers CU, et al. Nuclear translocation of beta-catenin and decreased expression of epithelial cadherin in human papillomavirus-positive tonsillar cancer: an early event in human papillomavirus-related tumour progression? Histopathology. 2011; 58(7): 1117-26.
27. Muller S, Su L, Tighiouart M, et al. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation. Cancer. 2008; 113(1): 97-107.
28. Liu LK, Jiang XY, Zhou XX, et al. Upregulation of vimentin and aberrant expression of E-cadherin/beta-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome. Mod Pathol. 2010; 23(2): 213-24.
29. Karayiannakis AJ, Syrigos KN, Alexiou D, et al. Expression patterns of the novel catenin p120cas in gastrointestinal cancers. Anticancer Res. 1999; 19(5C): 4401-5.
30. Ohkubo T, Ozawa M. p120(ctn) binds to the membrane-proximal region of the E-cadherin cytoplasmic domain and is involved in modulation of adhesion activity. J Biol Chem. 1999; 274(30): 21409-15.
31. Behrens J, Vakaet L, Friis R, et al. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol. 1993; 120(3): 757-66.